CTLA4 and neoplasm: Like the role of immune checkpoint receptors PD-1 and CTLA-4 play in suppressing effector T cell functions, the CD47-SIRPα signaling axis inhibits the antibody-dependent phagocytosis of tumor cells by macrophages.